VC  TriStar Technology Ventures

http://www.tstventures.com





     Office Locations:

3322 West End Ave., Suite 1110 11th Floor
Nashville, TN 37203
Phone: 615-515-9880
Fax: 615-515-9891

 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    TriStar Technology Ventures is an early stage venture fund that focuses on forming and investing in companies in the area broadly defined as Healthcare Innovation: biotech, pharmaceuticals, personalized medicine, medical devices, healthcare IT and healthcare services. TriStar forms and invests in companies at the pre-seed/seed stage. Initial investments may range from $100,000 to $1,000,000, with a target total investment of between $1,000,000 to $2,000,000 over the life of the investment. TriStar's strategy has a specific focus on technologies and companies emerging from universities and research institutions. Once a business qualifies to receive investment funds, it may continue receiving funds so long as it continues to be headquartered and principally operated in Tennessee with at least 60% of its employees located in Tennessee. In 2012, the firm raised the TriStar Technology Fund II in order to expand investment opportunities beyond Tennessee.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Brian Laden Ph.D. Co-Founder and Managing Director
    Christopher Rand Co-Founder and Managing Director
    Harry R. Jacobson M.D. Co-Founder and Partner
    Lisa McWilliams Director of Investor Relations

     

    Portfolio companies include:


      Bjond
        web link


      GenomOncology
        web link


      TVA Medical
        web link


     

    Recent News: